Journal of Neuroendocrinology leaps to the forefront!
The British Society of Neuroendocrinology (BSN) is proud to announce that the Impact Factor of the Journal of Neuroendocrinology (JNE) has increased to 4.1 as announced by Clarivate today. This puts JNE in the top quartile in both the Neuroscience and Endocrinology and Metabolism categories, which is excellent, but even more exciting is that JNE is now ahead of several of the other main journals in this field, including Endocrinology, Journal of Endocrinology , and the Journal of Neuroscience.
This achievement is a testament to the outstanding efforts of editors present and past: Professor Wouter de Herder (Translational and Clinical Editor-in-Chief from 2025), Professor Mike Lehman (Fundamental and Mechanistic Editor-in-Chief from 2024), Professor Julian Mercer (FMN Editor-in-Chief to 2023) and Professor Bob Millar (Translational and Clinical Editor-in-Chief from 2021 to 2024, and responsible for JNE’s expansion into the clinical and translational field). The efforts of these outstanding scientists, together with their editorial teams, have combined to put JNE into this stellar position in the field.
As a journal owned by the academic community, and run by it and for it, JNE’s success also enables the BSN to do more to support the next generation of neuroendocrinologists.
The Committee of the BSN and the Editors-in-Chief would like to extend their sincere thanks to all the editors, authors and reviewers who have made this possible, as well as to the societies, associations, and meeting organisers who have worked alongside us over the years.
We look forward to building further on this success and trust we can count on your continued support.
